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ABSTRACT
HAGOBIAN, T. A., K. A. JACOBS, A. W. SUBUDHI, J. A. FATTOR, P. B. ROCK, S. R. MUZA, C. S. FULCO, B. BRAUN, A.
GREDIAGIN, R. S. MAZZEO, A. CYMERMAN, and A. L. FRIEDLANDER. Cytokine Responses at High Altitude: Effects of
Exercise and Antioxidants at 4300 m. Med. Sci. Sports Exerc., Vol. 38, No. 2, pp. 276–285, 2006. Purpose: This study tested
the hypothesis that antioxidant supplementation would attenuate plasma cytokine (IL-6, tumor necrosis factor (TNF)-!), and Creactive protein (CRP) concentrations at rest and in response to exercise at 4300-m elevation. Methods: A total of 17 recreationally
trained men were matched and assigned to an antioxidant (N = 9) or placebo (N = 8) group in a double-blinded fashion. At sea level
(SL), energy expenditure was controlled and subjects were weight stable. Then, 3 wk before and throughout high altitude (HA), an
antioxidant supplement (10,000 IU "-carotene, 200 IU !-tocopherol acetate, 250 mg ascorbic acid, 50 2g selenium, 15 mg zinc) or
placebo was given twice daily. At HA, energy expenditure increased approximately 750 kcalIdj1 and energy intake decreased
approximately 550 kcalIdj1, resulting in a caloric deficit of approximately 1200–1500 kcalIdj1. At SL and HA day 1 (HA1) and day
HA13, subjects exercised at 55% of V̇O2peak until they expended approximately 1500 kcal. Blood samples were taken at rest, end of
exercise, and 2, 4, and 20 h after exercise. Results: No differences were seen between groups in plasma IL-6, CRP, or TNF-! at rest or
in response to exercise. For both groups, plasma IL-6 concentration was significantly higher at the end of exercise, 2, 4, and 20 h after
exercise at HA1 compared with SL and HA13. Plasma CRP concentration was significantly elevated 20 h postexercise for both groups
on HA1 compared to SL and HA13. TNF-! did not differ at rest or in response to exercise. Conclusion: Plasma IL-6 and CRP
concentrations were elevated following exercise at high altitude on day 1, and antioxidant supplementation did not attenuate the rise in
plasma IL-6 and CRP concentrations associated with hypoxia, exercise, and caloric deficit. Key Words: IL-6, TNF-!, C-REACTIVE
PROTEIN, HYPOXIA, ENERGY DEFICIT

A

thletes and military personnel who exercise or
work at high altitude experience hypoxia and, very
often, caloric deficit. Evidence indicates that the
stressors (i.e., hypoxia, exercise, caloric deficit) may
initiate an acute phase response (2,8,9,11,13,24), characterized by alterations in immune and inflammatory
responses (11,13,21), including increases in plasma interleukin-6 (IL-6), tumor necrosis factor-! (TNF-!), and
C-reactive protein (CRP) concentrations. Elevations in
plasma IL-6, TNF-!, and CRP concentrations may contribute to altitude-associated illnesses (e.g., acute mountain
sickness and high altitude pulmonary edema), which can
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compromise physical work capacity (8,24). Therefore,
preventing or attenuating the cytokine rise and the acute
phase response may be beneficial during prolonged or
intense physical work at high altitude.
Antioxidant supplementation has been shown to reduce
the plasma cytokine response to exercise at sea level
(23,27). Vassilakopoulos et al. (27) showed that an
antioxidant cocktail blunted the plasma IL-6 and TNF-!
responses to 45 min of exercise in untrained individuals,
whereas Phillips et al. (23) demonstrated that supplemen
tation reduced plasma IL-6 and CRP after eccentric
exercise. In theory, antioxidant supplementation may
counter the rise in free radical production, measured by
markers of oxidative stress, which underlies the acute
phase response (10,27). Based on results from an in vitro
study (10), Vassilakopoulos et al. (27) proposed a theory
that the exercise-induced cytokine increase is a reactive
oxygen species (ROS)–dependent pathway. In contrast,
others have shown that the exercise-induced plasma
cytokine increase is not attenuated with antioxidant
supplementation (17,21) and is not induced by oxygen free
radicals (21). Because the oxidative stress response is

sensitive to various exercise parameters, differences in the
mode, duration, and intensity of exercise could explain
previous contradictory findings. At high altitude, few
studies (11,13) have evaluated the plasma cytokine and
CRP responses to a controlled exercise bout and none have
tried to attenuate these responses with antioxidant supple
mentation.
Therefore, the primary purpose of this investigation was
to evaluate the efficacy of an antioxidant supplement in
reducing plasma cytokine and CRP concentrations associ
ated with the common conditions that occur at high altitude
(i.e., hypoxia, exercise, caloric deficit). To mimic the daily
total caloric deficit that is typically observed in individuals
living and working at high altitude, a lower energy intake
and higher energy expenditure were imposed. We hypoth
esized that (a) resting plasma IL-6, TNF-!, and CRP
concentrations would be elevated throughout the 14-d stay
at high altitude, (b) plasma IL-6, TNF-!, and CRP
concentrations would increase during and after prolonged
submaximal exercise at high altitude compared with sea
level, and (c) antioxidant supplementation would attenuate
the rise in plasma IL-6, TNF-!, and CRP concentrations
associated with hypoxia, exercise, and caloric deficit.

METHODS
Approach. A prospective, double-blind, placebocontrolled design was used to determine the efficacy of
antioxidant supplementation in reducing plasma cytokines
and CRP concentrations in response to the common con
ditions that can occur at high altitude (i.e., hypoxia, exer
cise, caloric deficit). Testing phases included 5 d at sea
level and 14 d at high altitude, with subjects ingesting an
antioxidant supplement or placebo during the high altitude
phase. The main outcome variables were plasma cytokines
(IL-6 and TNF-!) and CRP concentrations. Details of the
study are outlined below.

Study design. Subjects were first studied at sea level
(Palo Alto, CA, 15-m elevation, atmospheric pressure
748–762 torr) during a 7-d diet stabilization period,
followed by a 5-d testing period during which they resided
in the Clinical Studies Unit at the Veterans Affairs Palo
Alto Health Care System (VAPAHCS). At sea level,
energy expenditure was controlled and subjects were fed
a weight-stabilizing diet. Cytokine and CRP concentrations
were measured at rest and in response to exercise at sea
level day 1 (SL). At 3 wk before departure for high
altitude, subjects began taking an antioxidant or placebo
supplement twice a day and continued throughout their
2 wk stay at high altitude. Approximately 6 wk after the sealevel phase, subjects were flown to Colorado Springs, CO
(1850 m), where they spent the night in an apartment while
breathing supplemental oxygen to maintain sea-level oxy
gen saturation (Q97%). The next morning, subjects were
driven to the summit of Pikes Peak, CO (4300 m,
atmospheric pressure 458–464 torr) to the U.S. Army
Research Institute of Environmental Medicine (USARIEM)
facilities, while still breathing supplemental oxygen. Cyto
kine and CRP testing was repeated before and after exercise
on high altitude day 1 (HA1) and day 13 (HA13), and fasting
CRP was measured on days 3 (HA3), 5 (HA5), and 10
(HA10). While living at high altitude, energy intake and
energy expenditure was altered to cause a 30–40% energy
deficit (see below for details). The subjects resided on Pikes
Peak in the USARIEM laboratory facility for the entire 14-d
study. Figure 1 illustrates a timeline of the activities at sea
level and high altitude.
Subjects. A total of 18 healthy men (mean TSD; 25.1 T
4.9 yr, 77.7 T 8.2 kg, 178.1 T 4.2 cm) were recruited to
participate in the study from Stanford University and the
surrounding areas (Palo Alto or San Jose, CA) using flyers
and local newspaper advertisements. To participate in the
current investigation, potential volunteers had to be partic
ipating in 96 hIwkj1 of regular endurance exercise, have a

FIGURE 1—Timeline of activities at sea level (A) and
high altitude (B). SL, sea level; HA, high altitude; Ex,
exercise.

peak oxygen uptake (V̇O2peak) Q45 mLIkgj1Iminj1, be
able to complete a endurance cycle test for 1 h at 70–75%
of energy output for peak oxygen consumption, have a
body fat percentage between 5 and 16% measured by
seven-site skinfold, and have no history of residence at
altitudes 91500 m. All participants were in good overall
health, nonsmokers, and disease free as determined by
health history questionnaire and medical evaluation. Data
of one individual were omitted because of a medical
emergency unrelated to the study (final N = 17). Written
informed consent was obtained from all individuals, and
the institutional review boards at Stanford University and
USARIEM approved the study.
Screening tests. On admission to the Clinical Studies
Unit at the VAPAHCS, a resting electrocardiogram (ECG),
and a standard blood and urine chemistry panel was
conducted. Following medical clearance, body composition
was evaluated by seven-site skinfold test. Subjects then
performed a continuous progressive exercise test to
volitional exhaustion on a cycle ergometer (Sensormedics
800, Yorba Linda, CA). An initial workload of 100 W was
increased 30 W every 2 min until oxygen consumption
failed to increase or the subject stopped, despite strong
encouragement. During the test, expired air was analyzed
using an online system (Parvomedics TrueMax 2400,
Consentius Technologies, Sandy, UT), and V̇O2peak was
determined to be the highest 30-s value obtained. In addi
tion, heart rate (Polar Electro Inc. A1, Woodbury, NY),
rating of perceived exertion, and an ECG were continu
ously monitored during the test.
Antioxidant supplementation. Three weeks before
going to high altitude, subjects were matched on age, body
mass, V̇O2peak, body fat percentage, partial pressure of end
tidal volume CO2 (PETCO2), and hypoxic ventilatory
response (HVR), and assigned to either an antioxidant
supplement (AO; N = 9) or placebo (PL; N = 8) group in a
double-blinded fashion (Table 1). The AO consisted of a
capsule of ascorbic acid (250 mg), "-carotene (10,000 IU),
!-tocopherol acetate (200 IU), selenium (50 2g), and zinc
(15 mg), and the PL was an identical-looking and -tasting
cellulose capsule. Subjects were instructed to ingest the
supplement twice daily, once in the morning and once in
the evening, continuing throughout the high-altitude phase.
As reported previously by Subudhi et al. (26), the
antioxidant protocol elevated blood concentrations in the
AO group at high altitude compared with sea level for
!-tocopherol (14.9 T 5.5, 10.0 T 3.8, respectively) and
"-carotene (0.58 T 0.31, 0.26 T 0.17, respectively). The PL
group had similar !-tocopherol and "-carotene concen
trations to the AO group at sea level, with no subsequent
change at high altitude. Based on previous research that
has shown a reduction in cytokine concentrations and
markers of oxidative stress in response to an antioxidant
supplement (22,23,27), we formulated a broad-based
antioxidant cocktail composed of vitamins and minerals
to maximize the possible benefits of the supplement.
Energy intake, energy expenditure and body
composition. Subjects were fed a standardized diet

TABLE 1. Physical characteristics of matched groups.
Variable
N
Age (yr)
Body mass (kg)
Ht (cm)
Body fat (%)
V̇O2peak (mLIkgj1Iminj1)
LIminj1
PETCO2 (torr)
HVR

AO
9
24.6
77.5
180.6
7.6
57.0
4.4
40.4
0.9

(5.5)
(7.8)
(4.2)
(2.9)
(1.5)
(0.6)
(1.7)
(0.8)

PL
8
24.8
79.6
176.8
9.3
53.9
4.3
40.8
1.0

(4.0)
(8.7)
(4.2)
(3.8)
(10.1)
(0.8)
(2.4)
(0.7)

Values are mean (SD) for AO and PL. AO, antioxidant supplement group; PL, placebo
group; V̇O2peak, peak oxygen uptake; PETCO2, partial pressure of end-tidal carbon
dioxide; HVR, hypoxic ventilatory response.

throughout the study composed of whole foods (e.g., pasta,
bagels, cereal) containing modest levels of antioxidants (just
below the RDA). Energy intake was initially estimated
before the first day of sea-level testing with the Harris–
Benedict equation, using an activity factor between 1.5 and
1.9, and, if necessary, was adjusted during the next 7 d to
maintain body mass. After the weight-stabilization period,
energy intake was maintained for the next 4 d with the diet
composed of 63% carbohydrate, 23% fat, and 13% protein.
Energy expenditure was estimated from self-reported daily
activity logs in which the subjects recorded all activities for
each 24-h period in 15-min intervals using the ACSM
compendium of physical activities (1). On several occasions
for each subject, heart rate was monitored to assess energy
expenditure. While at sea level, subjects maintained their
normal exercise routine.
Military personnel exposed to field training exercises and
prolonged excursions (including high altitude) typically
experience a caloric deficit Q1000 kcalIdj1 mainly because
of elevated energy expenditure (5). The goal of the highaltitude phase of this study was to mimic the typical
undernutrition observed during these field training exer
cises and prolonged excursions at high altitude, therefore,
subjects were asked to increase their energy expenditure to
1200–1500 kcalIdj1 more than at sea level (40% of caloric
intake) while maintaining sea-level energy intake values.
At high altitude, energy expenditure was estimated as
described above. For all subjects, total daily energy
expenditure was adjusted with basal metabolic rate
(BMR), which was assessed by indirect calorimetry on
high-altitude days 2 through 6 and days 10 through 13. To
elevate energy expenditure, subjects had unlimited access to
treadmills, cycle ergometers, and rowing and ski machines,
and were required to participate on a hike for 1–3 h
(93650 m of elevation) at least three times throughout the
high-altitude phase. If subjects were unable to achieve their
targeted energy expenditure each day at high altitude,
energy intake was adjusted to reach a total energy deficit
of approximately 1200–1500 kcalIdj1. Subjects were given
continuous feedback on a daily basis to ensure that the
overall caloric deficit at high altitude was approximately
40% of their sea-level energy intake.
Fasted body mass was measured every morning at SL and
HA, and body fat percentage was evaluated at SL and at HA1,
HA3, HA5, HA10, and HA14 using skinfold calipers. Fatfree mass was calculated as body mass minus body fat mass.

Prolonged submaximal exercise cycling test.
Prolonged submaximal exercise cycling (SEC) tests were
performed on SL day 1 (after 7 d of diet stabilization), and
HA1 and HA13 on an electromagnetically braked cycle
ergometer (Sensormedics). Exercise was prohibited 36 h
before all trials, and energy intake was adjusted to account
for the lower energy expenditure the day before the SEC
test at HA. After a 12-h overnight fast, subjects consumed
a standardized breakfast (478 kcal) composed of 74%
carbohydrate, 14% fat, and 12% protein. Within 2 h after
consumption of the meal, subjects were required to
consume at least 250 mL of water. A catheter was then
inserted into a forearm vein and a venous blood sample
was taken at rest 2 h after eating. Subjects then rode the
cycle ergometer at a pedal speed between 70 and 90 rpm.
At sea level, subjects exercised at 55.0% T 4.1 of V̇O2peak
until approximately 1500 kcal was expended. At high
altitude, subjects exercised at the same relative intensity as
sea level (i.e., same percent of high altitude V̇O2peak), and
the same absolute workload on HA1 and HA13, again until
an energy expenditure of approximately 1500 kcal was
achieved. Previous research has shown that V̇O2peak at
4300 m is reduced by approximately 25% compared with
sea level (6); therefore, the relative intensity level at high
altitude was estimated using the sea-level V̇O2peak values
and the predicted decrement. The actual average reduction
in V̇O2peak determined on day 2 at HA was 27% (26),
meaning that the actual relative intensity during the SEC
test was 57.0% T 2.9 of V̇O2peak. Because of this reduction
during the SEC test, the absolute workload decreased
compared with sea level and the duration of exercise at
high altitude increased compared with sea level (193 T 25
vs 135 T 25 min, respectively). Oxygen consumption was
measured during the initial 5 min of rest and 15 min of
exercise, and then the last 5 min of every hour completed
to ensure the required exercise intensity was being
maintained. During exercise the same volume of water
was consumed during all tests. Heart rate and oxygen
saturation were recorded every 15 min. After completion of
exercise, subjects consumed a standardized lunch (738 kcal)
composed of 53% carbohydrate, 17% fat, and 29% protein.
Blood samples were collected at rest, at the end of
exercise, and 2, 4, and 20 h after exercise.
Resting C-reactive protein. Resting CRP was deter
mined after a 10- to 12-h overnight fast at SL and HA3,

HA5, and HA10. Exercise was prohibited a minimum of
14 h before obtaining the blood draw.
Biochemical and acute mountain sickness
analyses. Blood samples were collected in sterile syrin
ges and transferred to EDTA tubes, then immediately spun
in a refrigerated centrifuge (3,000 � g) for 15 min. The
plasma was aliquotated into polystyrene tubes and stored at
j80-C until analyzed. Plasma concentrations of IL-6 and
TNF-! were determined by high-sensitivity enzyme-linked
immunosorbent assay (ELISA) kits using 96-well plates
(R&D Systems, Minneapolis, MN), and plasma CRP
concentrations were analyzed by the Palo Alto VA
Laboratory using a high-sensitivity assay. Catecholamine
concentrations were determined by high-performance
liquid chromatography (HPLC; BioRad Model 1330 pump,
Model 1340 electrochemical detector) with electrochemi
cal detection as previously described (14). Acute mountain
sickness scores (AMS), assessed by Lake Louise and
Environmental Symptoms questionnaires (ESQ), were
determined at SL and throughout the HA stay (data
published elsewhere). In the present investigation, AMS
scores were used for correlations with plasma cytokine and
CRP concentrations.
Statistical analysis. Data were analyzed using SAS
Inc. software (Cary, NC). A mixed model three-way
ANOVA with one between factor (group) and two within
factors (day and time) was used to determine the group �
day � time interaction using a compound symmetric
covariate structure. Pearson product moment correlations
were used to assess the relationship of plasma cat
echolamines with plasma IL-6 or CRP concentrations,
and AMS with plasma IL-6 and CRP concentrations. When
appropriate, post hoc tests of significance were performed
with a Tukey HSD test. By convention, the a priori level of
significance was set at ! G 0.05.
RESULTS
Energy intake, energy expenditure, and body
composition. By design, energy intake and energy
expenditure were equivalent at SL (mean TSD; 3895 T
348 kcalIdj1 and 4078 T 531 kcalIdj1, respectively). At
HA, the planned dietary restriction and increased physical
activity resulted in a decreased energy intake and increased
energy expenditure of 3357 T 579 kcalIdj1 and 4723 T

TABLE 2. Body composition at sea level and high altitude.
Body mass (kg)
AO
PL
Fat mass (kg)
AO
PL
Fat-free mass (kg)
AO
PL

SL

HA Day 1

HA Day 3

HA Day 5

HA Day 10

HA Day 14

77.5 (7.8)
79.6 (8.7)

77.5 (7.7)
80.3 (8.9)

77.0 (7.6)
80.3 (9.0)

76.1 (7.6)*y
79.1 (8.7)*y

75.2 (7.5)*y
78.0 (9.1)*y

73.9 (7.5)*y
76.5 (8.8)*y

6.0 (2.5)
7.6 (3.7)

6.2 (2.6)
8.0 (3.8)

6.2 (2.8)
7.4 (5.4)

5.9 (2.3)
8.1 (4.6)

5.3 (2.3)*
7.5 (3.8)

5.0 (2.3)*
7.1 (4.3)*

71.6 (7.3)
72.0 (6.8)

71.2 (7.3)
72.9 (7.4)

70.2 (7.4)
72.2 (7.1)

69.9 (7.5)*y
70.6 (6.5)*y

69.0 (7.6)*y
69.5 (7.6)*y

68.6 (7.5)*
69.2 (7.2)*

Values are mean (SD) for AO and PL. * Significantly different than SL and HA day 1 (P G 0.05). ySignificantly different than previous measurement (P G 0.05). AO, antioxidant
supplement group; PL, placebo group; SL, sea level; HA, high altitude.

significantly reduced in both groups by HA day 14
compared with sea level. Body composition changes over
the course of the study are presented in Table 2.
Prolonged submaximal exercise cycling test. No
difference was seen in steady-state V̇O2 during exercise
between the AO and PL groups at SL (31.4 T 0.8 vs 29.7 T
5.6 mLIkgj1Iminj1, respectively), HA1 (21.9 T 0.8 vs

FIGURE 2—Plasma IL-6 concentrations at rest, at the end of exercise
(Ex), and after exercise (2, 4, and 20 h) for AO (A) and PL (B) groups.
Values are mean (SEM). * Significantly different than rest for SL, HA
day 1, and HA day 13 (P G 0.001); y HA day 1 significantly different
than SL and HA day 13 (P = 0.035). AO, antioxidant supplement
group; PL, placebo group; IL-6, interleukin-6; SL, sea level; HA, high
altitude; Ex, end of exercise.

484 kcalIdj1, respectively, for a total energy deficit of
1385 T 531 kcalIdj1. The total energy deficit for the AO
and PL groups was similar at HA (1400 T 465 kcalIdj1 and
1331 T 613 kcalIdj1, respectively). The resulting changes
in body mass, fat-free mass, and fat mass were similar
between the groups (Table 2). Body mass and fat-free mass
were reduced approximately 4.3 and 3.1 kg throughout the
duration of high altitude, respectively. Fat mass was

FIGURE 3—Plasma CRP concentrations at rest, at the end of exercise
(Ex), and after exercise (2, 4, and 20 h) for AO (A) and PL (B) groups.
Values are mean (SEM). * Significantly different than rest (P G 0.001)
for HA day 1; y HA day 1 significantly different than SL and HA day
13 (P G 0.001). AO, antioxidant supplement group; PL, placebo group;
CRP, C-reactive protein; SL, sea-level; HA, high altitude; Ex, end of
exercise.

20.6 T 3.9 mLIkgj1Iminj1, respectively), or HA13 (21.9 T
0.8 vs 20.4 T 4.3 mLIkgj1Iminj1, respectively), and the total
volume of O2 consumed for the SEC test (317 T 173 L) was
similar for each group. No difference was noted in oxygen
saturation during exercise between groups. Within the AO
and PL groups, oxygen saturation was significantly lower at
HA1 (72 T 8 and 75 T 5, respectively) compared with SL
(96 T 1 and 97 T 1, respectively) and HA13 (82 T 3 and 83 T
4, respectively). Heart rate was not different between groups.
Heart rate was significantly lower for AO and PL at HA13
(115 T 11 and 119 T 10 bpm, respectively) compared with SL
(129 T 7 and 138 T 12 bpm, respectively) and HA1 (129 T 11
and 124 T 20 bpm, respectively).
Plasma cytokines, C-reactive protein, and cate
cholamine concentrations. No group differences were
found between AO and PL in plasma IL-6, CRP, TNF-!,
or catecholamine concentrations. For both groups, plasma
IL-6 concentration was significantly higher at the end of
exercise, 2, 4, and 20 h after exercise at HA1 compared
with SL and HA13 (Fig. 2), with the maximal value for
both groups on HA1 approximately 100% greater com
pared with SL and HA13. At HA1, plasma IL-6 increased
approximately 42 times compared with rest for both groups
with peak values of 17.1 T 3.8 and 18.2 T 5.5 pgImLj1 for
AO and PL, respectively. Plasma catecholamine con
centrations and AMS scores were not correlated with
IL-6 (P 9 0.05). For both groups, plasma CRP con
centrations were significantly elevated 20 h after exercise
at HA1 compared with SL and HA13 (Fig. 3). The
maximal rise for both groups at HA1 was approximately
200% greater compared with SL and HA13. At HA1,
plasma CRP concentration increased approximately sixfold
compared with rest for both groups with peak values of
2.1 T 0.8 and 2.4 T 0.7 mgILj1 for AO and PL,
respectively. Plasma norepinephrine was significantly
correlated with CRP on HA1 at 20 h after exercise
(Fig. 4; combined data, r2 = 0.42, P = 0.005); however,

FIGURE 4—Relationship between 20 h after exercise plasma CRP
and plasma norepinephrine (data combined; P = 0.005, r2 = 0.42).
CRP, C-reactive protein.

TABLE 3. Plasma TNF-! (pgImLj1) response to the prolonged submaximal exercise
test for both groups.
Group

Test Day

AO

SL
HA day 1
HA day 13
SL
HA day 1
HA day 13

PL

Rest
2.1
1.9
1.6
1.8
2.0
1.9

(1.2)
(0.8)
(0.4)
(0.8)
(0.8)
(0.8)

End of
Exercise

2 h After
Exercise

4 h After
Exercise

1.8 (1.1)
1.7 (1.1)
1.7 (1.2)
1.7 (0.4)
2.1 (1.1)
1.7 (0.6)

1.7
1.6
1.9
1.6
1.8
1.5

1.7 (0.9)
1.7 (0.8)
1.8 (1.2)
1.7 (0.6)
1.8 (0.9)
1.3 (0.7)

(1.1)
(1.0)
(1.4)
(0.8)
(1.0)
(0.9)

Values are mean (SD) for AO and PL. AO, antioxidant supplement group; PL, placebo
group; TNF-!, tumor necrosis factor !; SL, sea level; HA, high altitude.

plasma epinephrine and AMS scores were not (P 9 0.05).
Plasma TNF-! concentration did not differ between any
conditions (Table 3). For both groups (data combined),
plasma epinephrine concentrations were significantly ele
vated at the end of exercise, 2, 4, and 20 h after exercise on
HA1 compared with sea level and HA13 (Fig. 6). Plasma
norepinephrine concentrations (data combined) tended to
be higher at HA1 and HA13 compared with SL, but did not
reach statistical significance (Fig. 6).
Resting C-reactive protein. No difference was seen
in resting plasma CRP concentration between the groups
(Fig. 5). Plasma CRP concentration was significantly
elevated at HA3 and HA5 compared with SL for both
groups, but returned to similar SL values at HA10. Plasma
CRP concentration tended to be higher for the AO group at
HA10 compared with the PL group because one subject_s
CRP value was approximately 560% greater than the group
mean (10.1 vs 1.6 mgILj1, respectively). No significant
correlations were found between plasma norepinephrine or
epinephrine and resting CRP (P 9 0.05). Because CRP
concentrations initially rose over time at high altitude (days
3 and 5), it is possible that the elevation of plasma CRP

FIGURE 5—Resting plasma CRP concentrations at SL and HA days
3, 5, and 10. Values are mean (SEM). y HA day 3 and HA day 5
significantly different than SL for both groups (P = 0.028). AO,
antioxidant supplement group; PL, placebo group; CRP, C-reactive
protein; SL, sea level; HA, high altitude.

FIGURE 6—Plasma epinephrine (A) and norepinephrine (B) concen
trations at rest, at the end of exercise (Ex), and after exercise (2, 4,
and 20 h) for AO and PL groups (data combined). Values are
mean (SEM). * HA day 1 significantly different than SL and HA day
13 (P G 0.001). AO, antioxidant supplement group; PL, placebo group,
HA, high altitude; SL, sea level.

concentrations on HA1 at 20 h after exercise is a factor of
the duration of altitude exposure rather than the SEC test,
per se.
DISCUSSION
Military personnel or athletes working at high altitude
may experience several stressors (e.g., hypoxia, exercise,
energy deficit) that will initiate an acute phase response
and contribute to altitude-associated illness (8,9,11,13),

which may be detrimental to work capacity or performance
over time. In the present investigation, we evaluated the
efficacy of an antioxidant supplement in reducing the acute
phase response associated with hypoxia, exercise, and
caloric deficit at high-altitude exposure (4300-m elevation)
by measuring changes in cytokines and CRP responses in
subjects given a placebo or antioxidant supplement. We
found that plasma IL-6 and CRP concentrations were
elevated in response to exercise during acute high-altitude
exposure compared with sea level, although plasma TNF-!
concentrations were not elevated. The elevation in plasma
IL-6 and CRP concentrations in response to exercise, how
ever, did not persist at high altitude. In addition, resting
plasma CRP returned to similar sea-level values during the
14-d stay at high altitude. Finally, in contrast to our
primary hypothesis, antioxidant supplementation did not
attenuate the rise in plasma IL-6 and CRP concentrations
associated with hypoxia, exercise, and caloric deficit.
Antioxidant supplementation. Antioxidant supple
mentation in this investigation did not attenuate the rise in
plasma IL-6 or CRP concentrations, which is in agreement
with some studies performed at sea level and high altitude
(2,17,21), but not others (23,27). A few explanations for
the lack of effect of antioxidant supplementation in our
data may exist. First, it has been hypothesized that an
antioxidant supplement blunts the cytokine response
through a ROS-dependent pathway as an increase in
oxidative stress markers have been associated with elevat
ed production of cytokines (27). We, however, previously
reported that prolonged submaximal exercise at high
altitude did not induce any significant increases in oxida
tive stress markers (i.e., lipid hydroperoxides, reduced
glutathione, oxidized glutathione, and glutathione peroxi
dase) (26), even in the placebo group. The lack of ROS
response suggests that either no additional ROS were
generated or the endogenous production of antioxidants
was sufficient at matching the generation of ROS. Because
we saw an increase in cytokines without an elevation in
ROS, the contribution of ROS to cytokine production in
response to prolonged, submaximal exercise at high altitude
may be minimal, with other factors (e.g., skeletal muscle
contraction, depleted skeletal muscle glycogen stores,
increased sympathetic activity) possibly playing a more
significant role in elevating plasma cytokines. This would
minimize the effects of antioxidant supplementation on
cytokine production. Bailey et al. (2) also found a dis
association between markers of oxidative stress and plasma
cytokines in volunteers ascending to 4780 m. Although we
saw an elevation in plasma catecholamine concentrations
at the end of exercise (+20%), we must note that the inten
sity of the SEC test (approximately 55% V̇O2peak) may not
have been sufficiently strenuous to generate any ROS
production, diminishing the effects of the antioxidant
supplement. We chose the same relative exercise intensity
at sea level and high altitude instead of the same absolute
exercise intensity because, based on previous unpublished
observations, the relative exercise intensity of approxi
mately 55% of V̇O2peak was considered an upper limit for

prolonged, steady state exercise at acute high-altitude
exposure. Together, these contradictory studies suggest
that the contribution of ROS to cytokine production re
mains to be determined both at sea level and high altitude.
Second, previous reports have shown a reduction in
plasma cytokines with antioxidant supplementation in
untrained, but not trained individuals (17,21,23,27).
Indeed, resting antioxidant levels in endurance-trained
individuals have been shown to be higher than in sedentary
individuals (4), and antioxidant concentrations may stay
elevated during and after an exercise bout in trained
individuals (21). Therefore, the recreationally trained
subjects in this investigation may have had a natural
antioxidant defense system that was not further enhanced
by supplementation. Direct comparison between trained
and untrained individuals is difficult to interpret, however,
because exercise duration and intensity have been different
(17,27). To clarify this issue, future studies should directly
compare the impact of antioxidant supplementation on
cytokine production in trained and untrained subjects
exercising at the same exercise intensity and duration.
Finally, research has shown that plasma cytokine
concentrations are correlated with levels of plasma cat
echolamines. More specifically, IL-6 responses at rest and
during exercise are dependent on a strong "-adrenergic
component, and a "-adrenergic antagonist blocks the IL-6
response (19). Exercise combined with hypoxia further
increases the epinephrine response (15), which may
enhance the cytokine response at altitude. In this investi
gation, antioxidant supplementation may not have attenu
ated the rise in IL-6 and CRP because a strong adrenal
release of epinephrine in response to hypoxia may have
overridden the efficacy of the antioxidant supplement. In
contrast, Lundby et al. (11) found that the catecholamine
response to exercise at altitude did not significantly
contribute to elevated plasma IL-6 levels. In this investi
gation, plasma catecholamine concentrations were not
correlated with plasma cytokines. In summary, the results
of this investigation are not consistent with the hypothesis
that antioxidant supplementation attenuates the cytokine
and CRP response associated with high-altitude exposure,
prolonged submaximal exercise, and caloric deficit in
recreationally trained subjects.
Cytokine response. Previous research at high altitude
has shown that plasma IL-6 concentrations are elevated
during exercise at the same absolute (same work rate), but
not relative (same percentage of maximal work rate)
exercise intensity compared with sea level (11,13). We,
however, did show a twofold increase in plasma IL-6
on acute altitude exposure compared with sea level during
and after exercise at the same relative workload (~55%
of V̇O2peak) (Fig. 2). It may be that the increased dura
tion of exercise in our study at high altitude (resulting
in the same total energy flux) was sufficient to induce
a greater response in plasma IL-6 despite the similar
relative workloads. Indeed, a study by Lundby et al. (11)
demonstrated, with similarly recreationally trained
subjects working at a comparable work load as in our

study, a peak exercise and altitude-induced increase in
plasma IL-6 of only about 6 pgImLj1 after 1 h of exercise
compared with our observed increase of approximately
18 pgImLj1 after 3 h, suggesting that duration of exercise
may be important.
In contrast to the HA1 response, we did not show an
increase in plasma IL-6 concentrations in response to
exercise at HA13 compared with sea level (Fig. 2), which
is in disagreement with others (11,13). Because the
subjects in this investigation exercised a minimum of
4 hIdj1 for the entire duration at high altitude (~20%
increase above sea-level energy expenditure), they may
have adapted to the elevated energy expenditure, thereby
blunting the plasma IL-6 response during the 3-h exercise
test at HA13. Subjects completed the prolonged exercise
test more easily and expressed feelings of less weakness
and fatigue at HA13 compared with HA1, despite no
accompanying increase in V̇O2peak over the 14-d stay at
altitude (subjects were still working at the same relative
intensity). In addition, subjects displayed higher oxygen
saturation during the SEC test at HA13 compared with
HA1 (83 vs 73%, respectively; P G 0.05), suggesting that
acclimatization had occurred during the 14-d stay at high
altitude. In summary, our results suggest that acclimatiza
tion over a 14-d stay at high altitude, combined with
elevated energy expenditure, attenuates the rise in plasma
IL-6 concentrations in response to exercise initially observed
on HA1.
To our knowledge, this is the first investigation to
evaluate the plasma TNF-! response to a controlled bout of
exercise at high altitude. Because TNF-! is elevated after a
prolonged and intense exercise bout (e.g., marathon race)
at sea level (18), we predicted TNF-! would be elevated
after exercise at high altitude. In contrast to our hypothesis,
plasma TNF-! did not differ at either sea level or high
altitude. Both animal and human studies suggest that
circulating levels of IL-6 inhibit TNF-! production.
Mizuhara et al. (16) demonstrated that rIL-6 administration
in mice reduces TNF-! production by 40–50%. In humans,
Starkie et al. (25) demonstrated that both exercise and
infusion of rhIL-6 blunts circulating plasma levels of
TNF-!. In addition, Pedersen et al. (20) proposed that
exercise-induced elevations in TNF-! are caused by
endotoxemia only after extreme exercise (e.g., marathon
race), but other modes of aerobic exercise do not elevate
plasma TNF-!. Evidence seems to support this theory as
most, but not all, have shown increases after a marathon
race, but not more modest exercise (7,18). The lack of
change in plasma TNF-! concentration in this investigation
at both sea level and high altitude supports the theory that
prolonged cycle ergometer exercise is not a sufficient
stressor to elevate plasma TNF-!.
C-reactive protein response. Plasma concentration
of CRP, an acute-phase protein largely regulated by IL-6,
is augmented after exercise at sea level (3). Most studies at
high altitude have focused on the CRP response to acute
hypoxia (8) and not the combined effects of strenuous
exercise and hypoxia. We found that the plasma CRP

response after exercise at HA1 was elevated compared with
SL and HA13. It is possible that this elevation is related
to the increased plasma IL-6 response and heightened
sympathetic activity (Figs. 3 and 4). Research has
consistently shown that a rise in plasma IL-6 induces an
elevation in the hepatic-derived CRP 3–20 h after exercise
(24). Furthermore, the significant correlation in this
investigation between plasma norepinephrine and CRP
concentrations (Fig. 3) on HA1 at 20 h after exercise
suggests a potential link between increased sympathetic
activity and a rise in plasma CRP at high altitude. Plasma
norepinephrine is a good marker of increased sympathetic
activity (14,15), which can remain elevated for up to 14 d
of high-altitude exposure (15). We also saw elevated
resting norepinephrine concentrations throughout the 14-d
stay at high altitude, but no correlation was found between
plasma norepinephrine and plasma CRP concentrations
during the latter days of altitude exposure.
High-volume exercise training, with insufficient rest, will
initiate an acute phase response and is thought to continu
ously increase resting CRP levels (24); however, research
supporting this theory is minimal. In this investigation, the
resting plasma CRP response was augmented at high
altitude (Fig. 5). Subjects were asked to increase their
energy expenditure by approximately 1200–1500 kcalIdj1
at high altitude, but we were only partially successful
because energy expenditure increased approximately 750
kcalIdj1 and energy intake decreased approximately
550 kcalIdj1, resulting in an approximately 4.3-kg loss of
body mass over a 2-wk period. Nonetheless, the resting
plasma CRP response at HA10 (Fig. 5) and HA14 (Fig. 2)
returning to similar sea-level values was surprising and
contradicted our hypothesis. Our results are consistent
with research at sea level, which has shown that after
a period of increased training intensity and volume,
plasma CRP was either reduced or returned to baseline
values (12).
Methodological consideration. In the current inves
tigation, because we altered energy intake and expenditure
to induce a total energy deficit of approximately 1500
kcalIdj1 at high altitude and not at sea level, it is difficult

to determine the altitude influence, per se, on the cytokine
and CRP responses. We chose to mimic conditions that
military personnel or athletes may experience at high
altitude during intense physical work periods (e.g., hypox
ia, elevated energy expenditure, energy deficit), with the
idea that an antioxidant supplement might attenuate the
acute phase response commonly seen with these conditions
at high altitude. If the goal is to tease out the independent
effects of hypoxia, elevated energy expenditure, and
decreased energy intake, a more appropriate study design
should include a sea-level energy deficit period that would
be repeated at high altitude or a nonenergy deficit group at
high altitude.
In conclusion, we have demonstrated that plasma IL-6
and CRP concentrations are elevated at acute high-altitude
exposure compared with both sea-level and chronic highaltitude exposure in response to exercise at the same
relative intensity. Results from this investigation, how
ever, do not support the hypothesis that antioxidant
supplementation attenuates the plasma cytokine and CRP
response associated with high-altitude exposure, elevated
energy expenditure, and decreased energy intake.
Future research should focus on determining the inde
pendent effects of elevated energy expenditure and de
creased caloric intake at high altitude on the acute phase
response.
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